JDD in the Media

December Article Citations

By December 3, 2019No Comments
“Men may have different reasons for visiting a cosmetic surgeon’s office, but one fairly universal concern they share is wanting to maintain (or enhance) their masculinity.” 

The number of Nonsurgical aesthetic procedures performed for male patients is growing is growing rapidly. However, there is limited data on treatment principles and goals for the male aesthetic patient.

In an article from Dermatology Times,  Katie Hobbins cites findings from research published in the January 2018 issue of the Journal of Drugs in Dermatology ( The Male Aesthetic Patient: Facial Anatomy, Concepts of Attractiveness, and Treatment Patterns“) that reports a “lack of information available on male aesthetic treatments and goals contributes to the disproportionately small national percentage of men seeking the advice of a cosmetic physician when compared to women. “

Expert advisors met to discuss anatomical differences in male versus female facial anatomy related to aging, facial treatment preferences in aesthetically oriented men, and current dosing data for facial injectable treatments in male versus female patients.

Read Article Now

You May Also Like

Featured ArticlesJDD in the MediaLatest NewsJDD in the News: UV Light as a Workplace Hazard
September 2, 2026

JDD in the News: UV Light as a Workplace Hazard

Healio featured two Journal of Drugs in Dermatology studies in recent articles, including an article on UV light as an underappreciated workplace hazard. The study, "Sun Exposure and Cancer Outcomes…
Featured ArticlesJDD in the MediaLatest NewsJDD in the News: Ruxolitinib vs. Triamcinolone for Atopic Dermatitis
July 27, 2026

JDD in the News: Ruxolitinib vs. Triamcinolone for Atopic Dermatitis

MedPage Today/Dermatology World Weekly highlighted a Journal of Drugs in Dermatology study comparing a topical JAK inhibitor with a common topical steroid in atopic dermatitis (AD). The study, “Ruxolitinib Cream…
JDD in the MediaLatest NewsNailsNP/PA EducationManagement of Nail Toxicities From Fibroblast Growth Factor Receptor Inhibitors
June 30, 2026

Management of Nail Toxicities From Fibroblast Growth Factor Receptor Inhibitors

Nail Toxicities with FGFR Inhibitors — A JDD Systematic Review Worth Reading Have you read this article from the March 2026 issue of JDD? A systematic review covering reports through…